Noznesky Justin J

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
15
Insider Sells Sum
$6.69M

Insider Activity of Noznesky Justin J

According to the SEC Form 4 filings, Noznesky Justin J, being in a position of

  1. Chief Mktg & Strategy Officer at AtriCure, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 4500 shares for $136,800,
    over all time since 2018-02-15, has bought 0 shares, and sold 163719 shares for $6.69M.

The largest sale of all time was on 2021-06-21 and amounted to 21000 shares of AtriCure, Inc. for $1.6M.

Biography of Noznesky Justin J

No biography is available at this moment.

2024-05-01SaleAtriCure, Inc.
ATRC
Chief Mktg & Strategy Officer
1,500
0.003%
$24.09$36,135+5.42%
2024-04-01SaleAtriCure, Inc.
ATRC
Chief Mktg & Strategy Officer
1,500
0.0033%
$30.39$45,585-12%
2024-03-12SaleAtriCure, Inc.
ATRC
Chief Mktg & Strategy Officer
1,500
0.0033%
$36.72$55,080-25.18%
2021-06-25SaleAtriCure, Inc.
ATRC
Chief Mktg & Strategy Officer
4,119
0.0091%
$80.00$329,520-14.34%
2021-06-21SaleAtriCure, Inc.
ATRC
Chief Mktg & Strategy Officer
21,000
0.0465%
$76.36$1.6M-9.43%
2021-01-04SaleAtriCure, Inc.
ATRC
SVP, Mktg & Business Develop
23,397
0.0522%
$53.58$1.25M+33.95%
2020-04-17SaleAtriCure, Inc.
ATRC
SVP, Mktg & Business Develop
10,000
0.0241%
$40.00$400,000+13.66%
2020-04-07SaleAtriCure, Inc.
ATRC
SVP, Mktg & Business Develop
10,000
0.0229%
$35.00$350,000+22.22%
2020-01-02SaleAtriCure, Inc.
ATRC
SVP, Mktg & Business Develop
29,134
0.0749%
$32.89$958,217+23.93%
2019-06-17SaleAtriCure, Inc.
ATRC
SVP, Mktg & Business Develop
10,000
0.0269%
$30.00$300,000+5.18%
2019-04-30SaleAtriCure, Inc.
ATRC
SVP, Mktg & Business Develop
15,000
0.0402%
$30.00$450,000+0.83%
2019-04-15SaleAtriCure, Inc.
ATRC
SVP, Mktg & Business Develop
12,569
0.0339%
$27.64$347,407+9.21%
2018-08-15SaleAtriCure, Inc.
ATRC
SVP, Mktg & Business Develop
8,000
0.0239%
$30.32$242,560+1.45%
2018-05-15SaleAtriCure, Inc.
ATRC
SVP, Mktg & Business Develop
8,000
0.0237%
$23.05$184,400+28.88%
2018-02-15SaleAtriCure, Inc.
ATRC
SVP, Mktg & Business Develop
8,000
0.024%
$17.03$136,240+71.72%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.